Tausif Butt
President en Idorsia Pharmaceuticals US, Inc. .
Cargos activos de Tausif Butt
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Idorsia Pharmaceuticals US, Inc. | President | 05/09/2023 | - |
Historial de carrera de Tausif Butt
Antiguos cargos conocidos de Tausif Butt.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CHEMOCENTRYX, INC. | Chief Operating Officer | 24/02/2021 | 20/10/2022 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2019 | 01/01/2021 |
Formación de Tausif Butt.
| Imperial College London | Graduate Degree |
| University of Brighton | Undergraduate Degree |
Estadísticas
Internacional
| Reino Unido | 4 |
| Estados Unidos | 3 |
Operativa
| Chief Operating Officer | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| Empresas privadas | 2 |
|---|---|
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA. | Health Technology |
| Idorsia Pharmaceuticals US, Inc. |
- Bolsa de valores
- Insiders
- Tausif Butt
- Experiencia
